You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Intermediate risk myelofibrosis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pre-fibrotic Myelofibrosis Trial in Taipei, Taiwan, 100 (Ropeginterferon Alfa-2B Prefilled Syringe [Besremi])

Recruiting
  • Pre-fibrotic Myelofibrosis
  • Ropeginterferon Alfa-2B Prefilled Syringe [Besremi]
  • Taipei, Taiwan, 100, Taiwan
    National Taiwan University Hospital
Feb 7, 2023

Myelofibrosis Trial in Hangzhou (Jaktinib, Placebo to match Hydroxycarbamide, Hydroxycarbamide Tablets)

Recruiting
  • Myelofibrosis
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital of Medical School of Zhejiang Univ
Nov 28, 2022

Myelofibrosis Trial (Momelotinib)

Available
  • Myelofibrosis
  • (no location specified)
Oct 12, 2022

Myelofibrosis Trial in Paris (Ruxolotinib)

Completed
  • Myelofibrosis
  • Paris, France
    ROBIN
Jul 26, 2022

Myelofibrosis Trial in Hangzhou (Jaktinib HCl tablets)

Recruiting
  • Myelofibrosis
  • Jaktinib hydrochloride tablets
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital of Medical School of Zhejiang Univ
Nov 29, 2021

Primary Myelofibrosis Trial in Japan (Fedratinib)

Recruiting
  • Primary Myelofibrosis
  • Suwa, Nagano, Japan
  • +25 more
Jan 18, 2023

Myelofibrosis Trial in China (TQ05105 Tablets, TQB3617 Capsules)

Not yet recruiting
  • Myelofibrosis
  • TQ05105 Tablets
  • TQB3617 Capsules
  • Guangzhou, Guangdong, China
  • +19 more
Nov 7, 2023

Primary Myelofibrosis, Prefibrotic Stage, Myelofibrosis Trial in Hong Kong (Ropeginterferon alfa-2b)

Recruiting
  • Primary Myelofibrosis, Prefibrotic Stage
  • Myelofibrosis
  • Ropeginterferon alfa-2b
  • Hong Kong, Hong Kong
    Department of Medicine, the University of Hong Kong, Queen Mary
Jul 25, 2021

Myelofibrosis, Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis Trial in Hangzhou (Jaktinib HCl tablets)

Recruiting
  • Myelofibrosis
  • +3 more
  • Jaktinib hydrochloride tablets
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital of Medical School of Zhejiang Univ
Jun 11, 2021

Myelofibrosis Trial in Worldwide (BMS-986158, Ruxolitinib, Fedratinib)

Recruiting
  • Myelofibrosis
  • La Jolla, California
  • +36 more
Jan 13, 2023

Myelofibrosis Trial in Worldwide (Imetelstat 4.7 mg/kg, Imetelstat 9.4 mg/kg)

Completed
Has Results
  • Myelofibrosis
  • Imetelstat 4.7 mg/kg
  • Imetelstat 9.4 mg/kg
  • Birmingham, Alabama
  • +71 more
Aug 17, 2021

Rhabdomyosarcoma Trial in Palo Alto, Memphis, Fort Worth (Vincristine, Dactinomycin, Cyclophosphamide)

Not yet recruiting
  • Rhabdomyosarcoma
  • Palo Alto, California
  • +2 more
Aug 27, 2023

Pulmonary Embolism Trial in Milano (ultrasound-assisted, catheter-directed thrombolysis)

Recruiting
  • Pulmonary Embolism
  • ultrasound-assisted, catheter-directed thrombolysis
  • Milano, Italia, Italy
    ASST GOM Niguarda
Nov 21, 2023

Intermediate to High-risk Asymptomatic Sportsmen With Exercise

Completed
  • Electrocardiography
  • Screening stress test on a bicycle ergometer (usual practise)
  • Saint-Étienne, France
    Centre Hospitalier de Saint-Etienne
Sep 6, 2023

Anal Squamous Cell Carcinoma Trial (Radiotherapy - Low risk group, Radiotherapy - Standard risk group, Radiotherapy -

Not yet recruiting
  • Anal Squamous Cell Carcinoma
  • Radiotherapy - Low risk group
  • +3 more
  • (no location specified)
Sep 18, 2023

Prostate Cancer Trial in Guangzhou ([18F]Florastamin Injection)

Recruiting
  • Prostate Cancer
  • [18F]Florastamin Injection
  • Guangzhou, China
    Sun Yat-sen University Cancer Center
Aug 21, 2023

Localized Prostate Carcinoma, Castration-Naive Prostate Cancer, Intermediate Risk Prostate Cancer Trial in Turku (Degarelix,

Not yet recruiting
  • Localized Prostate Carcinoma
  • +3 more
  • Degarelix
  • MRI-guided transurethral ultrasound ablation (TULSA)
  • Turku, Southwest Finland, Finland
    Turku University Hospital
Jun 14, 2023

Smoldering Multiple Myeloma Trial (Selinexor)

Not yet recruiting
  • Smoldering Multiple Myeloma
  • (no location specified)
Oct 27, 2022

Pulmonary Embolism Subacute Massive Trial (Mechanical embolectomy: by hydromechanical defragmentation by pigtail, Suction

Not yet recruiting
  • Pulmonary Embolism Subacute Massive
  • Mechanical embolectomy: by hydromechanical defragmentation by pigtail
  • Suction embolectomy by the Penumbra Indigo aspiration system
  • (no location specified)
Nov 9, 2022

Prostate Cancer Trial (Piflufolastat F 18 Intravenous Solution [PYLARIFY])

Not yet recruiting
  • Prostate Cancer
  • Piflufolastat F 18 Intravenous Solution [PYLARIFY]
  • (no location specified)
Oct 3, 2023

Screening CEDM in Intermediate and High-Risk Patient Populations

Completed
  • Breast Cancer
  • Contrast Enhanced Digital Mammography
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 18, 2023

Prostatic Cancer Trial (High Dose Brachytherapy, Stereostatic Body Radiation Therapy)

Not yet recruiting
  • Prostatic Cancer
  • High Dose Brachytherapy
  • Stereostatic Body Radiation Therapy
  • (no location specified)
Mar 3, 2023

Myelofibrosis Trial in Worldwide (Imetelstat, Best Available Therapy (BAT))

Recruiting
  • Myelofibrosis
  • La Jolla, California
  • +165 more
Aug 19, 2022

MDS, MDS, Thrombocytopenia Trial (Placebo, Romiplostim)

Completed
Has Results
  • MDS
  • +2 more
  • Placebo
  • Romiplostim
  • (no location specified)
Nov 4, 2022

Prostate Cancer Trial in New Haven (Relugolix 120 MG [Orgovyx], SBRT standard of care radiotherapy treatment)

Not yet recruiting
  • Prostate Cancer
  • Relugolix 120 MG [Orgovyx]
  • SBRT standard of care radiotherapy treatment
  • New Haven, Connecticut
    Yale Cancer Center
Oct 26, 2023